- £15.97m
- £15.66m
- £2.45m
- 12
- 21
- 85
- 29
REG - EMV Capital PLC - Expansion of Senior Finance Leadership Team
AnnouncementRCS - EMV Capital PLC - Portfolio Update
AnnouncementREG - EMV Capital PLC - Interim Results and Investor Presentation
AnnouncementREG - EMV Capital PLC - Asset Purchase Agreement with Destiny Pharma
AnnouncementREG - EMV Capital PLC - Notice of Interim Results
AnnouncementREG - EMV Capital PLC - Result of AGM
AnnouncementREG - EMV Capital PLC - Office move and Related Party Transaction
AnnouncementREG - EMV Capital PLC - Q-Bot Limited Fundraising
AnnouncementREG - EMV Capital PLC - TR-1
AnnouncementREG - EMV Capital PLC - Notice of AGM and Annual Report & Accounts
AnnouncementREG - EMV Capital PLC - Director/PDMR Shareholding
AnnouncementREG - EMV Capital PLC - Preliminary results for the year ended 31 Dec 2024
AnnouncementREG - EMV Capital PLC - PDS: Q1 Results and Clinical and Corporate Update
AnnouncementREG - EMV Capital PLC - TR-1
AnnouncementREG - EMV Capital PLC - PDS: Q4 Results and Clinical Programs Update
AnnouncementREG - EMV Capital PLC - PDS: VERSATILE-003 Phase 3 Clinical Trial
AnnouncementREG - EMV Capital PLC - PDS: up to $22mn Registered Direct Offering
AnnouncementREG - EMV Capital PLC - PDS Biotech reaffirms guidance for clinical trial
AnnouncementREG - EMV Capital PLC - ProAxsis: Status Update and Proposed Fundraise
Announcement